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The AIDS Disease of CD4C/HIV Transgenic Mice
Shows Impaired Germinal Centers and Autoantibodies
and Develops in the Absence of IFN- and IL-6
phage/dendritic cell lineages (Hanna et al., 1998a,
1998b). Studies with several HIV-1 mutant Tg lines re-
vealed that nef was largely responsible for the develop-
ment of the AIDS-like pathology (Hanna et al., 1998b).
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production by FDC has also been demonstrated to pro-
mote GC development and Ab production (Kopf et al.,The mechanisms responsible for degeneration of ger-
1998), and IL-6 has been shown to be involved in B cellminal centers (GC) and follicular dendritic cell (FDC)
terminal differentiation (Morse et al., 1997).networks during progression to AIDS remain elusive.
Lymphoid tissues are the main reservoir for HIV-1,Here, we show that CD4 T cells from CD4C/HIV-1
where ongoing cellular interactions allow for the virusTg mice, which develop a severe AIDS-like disease,
to be produced and persist. More precisely, the GCexpress low levels of CD40 ligand. Accordingly, GC
compartment comprises the major cellular source forformation, FDC networks, and immunoglobulin iso-
viral replication and storage (Pantaleo et al., 1993; Pan-type switching are impaired in these animals. How-
taleo and Fauci, 1995; Embretson et al., 1993; Fox et al.,ever, Tg B cells respond to in vitro CD40 stimulation.
1991; Tenner-Racz and Racz, 1995). Indeed, activated/Total serum IgG levels are reduced in Tg mice,
memory CD4 T cells, which traffic to GC, are the majorwhereas total IgM levels are increased with a signifi-
cells involved in viral replication and production. Also,cant amount showing DNA specificity. IFN-- and IL-
although not infected with HIV-1, FDC act as a significant6-deficient CD4C/HIV Tg mice also develop the AIDS-
storage compartment for virions (Pantaleo and Fauci,like disease and produce auto-Ab. Thus, CD4C/HIV
1995; Tenner-Racz and Racz, 1995).Tg mice have immune dysfunction accompanied by
Dysfunctional GC formation is a hallmark of SIV- andautoimmune responses.
HIV-1-mediated diseases (Pantaleo et al., 1993; Panta-
leo and Fauci, 1995; Rosenberg et al., 1997). ProgressionIntroduction
to AIDS is associated with the disruption and involution
of the GC architecture concomitant with the loss of virionWe have previously reported that CD4C/HIV-1 Tg mice
trapping capacity in lymphoid organs due to the degen-develop a severe disease closely resembling pediatric
eration of FDC networks. Whether the latter results fromAIDS (Hanna et al., 1998a, 1998b). These mice die pre-
cytopathic effects remains to be established. However,maturely, suffering from severe wasting as well as kid-
given that FDC network formation depends on both Bney, lung, and heart pathologies. A gradual atrophy of
and T cell signals (MacLennan, 1994; Kosco-Vilbois etthe lymphoid organs also occurs with preferential loss
al., 1997), the gradual loss of T cells and immune dys-of CD4 T cells, which is accompanied by a downregula-
functions associated with AIDS are likely to contributetion of the CD4 molecule and a loss of responsiveness
to GC involution and FDC network destruction.to mitogenic stimuli. In contrast, B cell numbers are
The B cell compartment is most probably affected byincreased in Tg lymph nodes (LN) and spleens.
HIV-1 through an indirect mechanism, as the virus hasExpression of HIV-1 in Tg mice is under the control
not been shown to infect or replicate in B cells in vivoof the transcriptional regulatory elements of the human
(Shearer, 1998; Edelman and Zolla-Pazner, 1989). B cellCD4 gene and has thus been detected in immature and
hyperreactivity and auto-Ab production are often re-mature CD4 T cells as well as in cells of the macro-
ported in AIDS patients (Pantaleo and Fauci, 1995;
Shearer, 1998; Root-Bernstein, 1990; Ditzel et al., 1994).6 Correspondence: jolicop@ircm.qc.ca (P.J.), poudrij@ircm.qc.ca
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Herndier et al., 1994). These pathogeneses involve cyto- that the delivery of T helper functions for B cell activation
might be impaired. To further address this issue, thekines such as IL-6, IL-10, and IL-13 (Emilie et al., 1997).
influence of CD4 T cell help on B cell activation in vivoIn order to understand the effects of HIV-1 proteins
was assessed by measuring the immune response toon CD4 T helper functions in relation to B cell re-
chicken ovalbumin (OVA). A paucity in GC formationsponses, we have studied the lymphoid compartment
in response to OVA was observed in draining LN ofof CD4C/HIV-1 Tg mice, assessing their capacity to gen-
immunized Tg mice (Figure 2). The formation of peanuterate GC reactions and develop FDC networks. In addi-
agglutinin (PNA) binding GC, observed in non-Tg micetion, we have investigated whether the cytokines IFN-
sacrificed 7 days following the primary immunization,and IL-6, known to be involved in T and B cell functions,
was largely absent from Tg animals (Figure 2B). In addi-were required for the development of the AIDS-like
tion, the FDC network was markedly reduced in Tg ani-disease.
mals, as compared to the non-Tg controls (Figure 2C).
Also, the number of large IgM B cells, possibly repre-Results
senting plasma cells, appeared to be increased in the Tg
LN (Figures 2B and 2C). Similar findings were obtained inPhenotype of CD4 T Cells from CD4C/HIVMutA Tg Mice
LN from Tg mice 10 days following primary (i.e., at theHIV-1 infection is characterized by the loss in number
peak of GC reactions; Figure 2A) or 5 days followingand function of CD4T cells, as well as a downregulation
secondary (data not shown) immunizations with OVA,of their CD4 surface expression (Shearer, 1998). In
although a few small foci of PNA binding cells could beCD4C/HIV Tg mice, CD4 T cells are also preferentially
observed in the follicles of some Tg LN. In situ hybridiza-and progressively lost during the course of the disease
tion (ISH) performed on LN sections from the Tg miceand exhibit a downregulation of CD4 surface expression
revealed that HIV transgene-expressing cells were con-(Hanna et al., 1998b; Figure 1A). Based on these obser-
centrated mainly in the T cell zone and subcapsularvations, the function of CD4 T cells was further investi-
sinus (Figure 2I).gated in the CD4C/HIVMutA Tg mice, expressing rev, env,
In the spleens, an absence of PNA binding GC wasand nef of HIV-1. Using flow cytometry (FACS), lower
also observed in the Tg mice following OVA immuniza-levels of the costimulatory molecule CD40L were found
tion (Figures 2D and 2E). The T cell zone was markedlyto be expressed in Tg CD4 T cells as compared to non-
decreased in the sections from Tg as compared to non-Tg CD4 T cells, following in vitro stimulation with anti-
Tg animals (Figures 2D–2F). An enlarged marginal zoneCD3 plus anti-CD28 mAb. However, CD69 expression
(MZ) could be observed in Tg mice (Figures 2D–2F) withwas upregulated from 10% to 94% by non-Tg T cells
numerous Mac-1 macrophages (Figure 2F), and strongand from 25% to 87% by Tg T cells (Figure 1B), and
PNA binding was detected on large cells of this MZ areasimilar numbers of IL-2-producing CD4 T cells were
(Figures 2D and 2E), including on CD11c as well asdetected by intracellular staining in cultures from non-
Moma-1 cells (data not shown). In addition, evaluationTg and Tg mice (X.W., unpublished data), suggesting
at higher magnification revealed that more large IgMthat Tg CD4 T cells can respond to a certain extent to
B cells, possibly plasma cells, were found in the red pulpin vitro stimulation.
of Tg mice than in non-Tg controls, often surrounded byThe capacity to produce cytokines of a differentiated
large PNA binding cells (Figure 2E). Interestingly, thehelper phenotype was also assessed. After 2 days of
MZ corresponded to the splenic area where high levelsstimulation with anti-CD3 plus anti-CD28 mAb, the num-
of HIV-1 expression were found by ISH along with theber of IFN--producing CD4 T cells was observed to be
T cell zone (Figure 2M). Analysis of the spleen also re-
higher in cultures from Tg mice, whereas IL-4-producing
vealed follicular hyperplasia in some Tg animals (Figures
CD4 T cells could not be detected in either cell popula-
2M and 2O).
tion (data not shown). In order to further assess the Strikingly, strong PNA binding whose intensity was
capacity of Tg CD4 T cells to produce IL-4, T cells comparable to that obtained for GC cells (Figures 2A,
were first cultured for 5 days with anti-CD3 plus anti- 2B, and 3A) and for the thymus of both non-Tg and Tg
CD28 mAb and restimulated in the same conditions for animals (Figure 3D) was observed on cells of the T cell
another 3 days, as described previously (Poudrier et zone of both LN and spleen in Tg mice (Figures 2A
al., 1998). Under these conditions, Tg cultures showed and 3A–3C), regardless of whether the mice had been
significant cell death and the remaining CD4 T cells immunized (Figure 3). Some of these PNA cells were
did not produce IL-4, but a higher proportion of IFN-- CD8 (as assessed by double labeling; data not shown).
producing Tg CD4 T cells was observed, as compared However, the downregulation of CD4 prevented the ob-
to non-Tg CD4 T cells (Figure 1C). FACS analysis using taining of similar data for CD4 T cells. Nevertheless,
the DX5 mAb revealed the absence of NK cells in the those PNA cells are most probably T cells, as most of
CD4 T cell cultures (data not shown), ruling out a possi- the cells in the Tg T zone are TcR (data not shown).
ble contribution of NK cells to the IFN- production. PNA binding does not appear to involve B cells, as there
Interestingly, this profile of high levels of IFN- and low was an absence of PNA binding by IgM, IgD, or B220
levels of IL-4 observed in CD4C/HIVMutA Tg mice reflects cells (data not shown). PNA binding cells were also prev-
what is found in human AIDS (Graziosi et al., 1994; Than alent in the MZ of the Tg spleen (Figures 2D and 2E)
et al., 1997; Emilie et al., 1994). and LN subcapsular sinuses (Figures 2A, 2B, and 3A),
although for this latter site less frequently than in the
GC Formation Is Impaired in Tg Mice MZ. Strong PNA binding therefore appears to follow the
The decreased level of CD40L on Tg CD4 T cells as pattern of transgene expression in LN and spleen of Tg
mice. Although the T cell zone in Tg mice is diminishedwell as the reduced capacity to produce IL-4 suggested
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Figure 1. Phenotype of Tg CD4 T Cells
(A) FACS analysis of CD4 expression on total
peripheral LN cells from non-Tg and Tg mice
(4-month-old). The percentage of CD4 cells
and mean fluorescence intensity are shown.
The same observations were found for spleen
and mesenteric LN. The results showing CD4
downregulation and reduction of CD4 T
cells, to various degrees depending on the
age of the animal, are representative of 12
experiments, analyzing mice of 1.5 to 4
months in age.
(B–C) High-density CD4 T cells from periph-
eral LN of non-Tg and Tg mice (2-month-old).
(B) Expression of CD40L and CD69 following
a 12-hr culture period on anti-CD3-coated
plates in the presence of anti-CD28 mAb.
(C) IFN- and IL-4 expression was detected
by intracellular staining after an initial 5-day
stimulation on anti-CD3-coated plates in the
presence of anti-CD28 mAb, followed by a
3-day restimulation under the same condi-
tions. The percentage of cytokine-positive
cells and mean fluorescence intensity are
shown. The data are representative of at least
four experiments.
in size, it consists mainly of TcR cells as well as of a we found that Tg mice expressing a myristylation-nega-
few MHC class II cells (data not shown) and IgM B tive mutant Nef allele (CD4C/HIV-NefMyr) did not de-
cells (Figures 2A and 3B), reflecting a normal cellular velop an AIDS-like disease (Z.H., unpublished data), de-
distribution (Steinman et al., 1997). Only in very severe spite the fact that they still exhibit a downregulation of
disease states did we observe a prevalence of B cells CD4 on the surface of their T cells which is equivalent
in the T cell zones of Tg mice (data not shown). to that observed with wild-type Nef (30%–50% decrease
in mean fluorescence intensity). Interestingly, these
CD4C/HIV-NefMyr mice can develop normal GC in re-GC Formation Is Not Impaired in Tg Mice Harboring
sponse to immunization with OVA both in LN (Figurea Mutated Nef Allele
2G) and spleen (data not shown). These results stronglyIt could be argued that the downregulation of CD4 on
suggest that mechanisms other than CD4 downregula-T cells may be contributing to the lowered T helper
tion alone are responsible for the phenotype observedfunctions found in these Tg mice and consequently to
some of the pathological changes observed. However, in the CD4C/HIVMutA Tg mice.
Immunity
176
Figure 2. Impaired GC Formation and Transgene Expression in LN and Spleen of Tg Mice
(A–C) The formation of GC assessed on cryosections of draining LN taken at day 10 (A) or day 7 (B and C) following primary immunization
with OVA. PNA binding is in green and IgM expression is in red. Magnification, 10 (A) and 40 (B and C). IgM expression is shown in red
and the FDC network in green (C). Coexpression is in yellow. Insets in (C) highlight the extent of FDC labeling.
(D–F) The formation of GC assessed on splenic cryosections obtained at day 10 following a primary immunization with OVA. PNA binding (D
and E) and Mac-1 (F) are in green and IgM expression is in red. A higher magnification (20) of the dotted portion of (D) (10) is shown in
(E). Sections were analyzed by fluorescence (A–C and F) or confocal (D and E) microscopy. Data are representative of at least four experiments
(16 mice). Arrows point to large IgM cells (B–E).
(G) The formation of GC was assessed on cryosections of draining LN from non-Tg, CD4C/HIVMutG (Tg-NefWT), and CD4C/HIV-NefMyr (Tg-
NefMyr) mice, taken at day 10 following primary immunization with OVA. Analysis by confocal microscopy shows PNA binding in green and
IgM expression in red. Magnification, 10.
(H–O) Transgene expression in LN (I) and spleen (M) of CD4C/HIVMutA Tg mice. Draining LN from an OVA-challenged Tg mouse was hybridized
Immune Dysfunctions in HIV-1 Tg Mice
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Ig Isotype Switching Is Impaired in Tg Mice expansion of the mature B cell compartment is favored
by factors outside the BM.Ig isotype switching occurs due to T cell-dependent B
cell responses during GC reactions. Accordingly, the
levels of various Ig isotypes in the sera of mice following
B Cells from Tg Mice Are Not Impaired in Theirprimary (data not shown) and secondary (Figure 4A)
Capacity to Isotype Switch In Vitroimmunizations with OVA were measured. Significantly
In order to further clarify the status of B cells in thereduced levels of OVA-specific IgG1, IgG2a, and IgG2b
Tg mice, the phenotype and function of purified smallwere observed in the sera of Tg mice as compared
resting B cells were investigated. FACS analysis re-to levels in non-Tg controls. The production of OVA-
vealed that Tg B cells isolated from the LN and spleens
specific IgM was less affected, although most Tg ani-
of mice of different age groups showed no change in
mals had significantly lower levels than non-Tg mice. the levels of surface expression for IgM, MHC class I,
These results indicate that B cells from CD4C/HIVMutA Tg and CD40 as compared to B cells from non-Tg lit-
mice have a reduced capacity to mount a mature Ag- termates (data not shown). Only in older animals was a
specific Ab response. Interestingly, this capacity to Ig slightly diminished level of MHC class II observed. Rest-
isotype switch was maintained in the CD4C/HIV- NefMyr ing Tg B cells did not express altered levels of CD25,
Tg mice (data not shown). CD44, CD69, CD80, or CD86 on their surface when com-
pared to non-Tg B cells (data not shown). In vitro analy-
sis of B cell function showed similar amounts of cellsHigh Level of Serum IgM and Presence of Anti-DNA
producing IL-10 in response to lipopolysaccharide (LPS)Ab in Tg Mice
in non-Tg and Tg mice (data not shown). However, Tg
The impaired responses of Tg B cells to T-dependent B cells proliferated spontaneously to a slightly greater
Ag stimulation prompted us to assess the general status extent than non-Tg B cells and had a slightly elevated
of the humoral compartment in CD4C/HIVMutA Tg mice. response to CD40 stimulation (Figure 4C). Also, secreted
Total IgG1, IgG2a, and IgG2b levels were significantly de- IgM levels were found to be slightly higher in the super-
creased in the serum of Tg mice from different age natants of unstimulated Tg B cells than that of non-Tg
groups as compared to non-Tg controls (Table 1 and B cells (Figure 4D). Since Tg B cells proliferated 1.5-
data not shown). Total serum IgM levels tended, how- fold better in vitro than non-Tg B cells, the modest in-
ever, to be higher in Tg mice than in non-Tg controls. crease of IgM levels observed appeared to reflect a
IgE levels were comparable in sera from non-Tg and Tg greater number of cells producing these molecules
mice. This pattern of IgG production further exemplifies rather than a higher number of molecules produced per
cell. Total IgM and IgG1 production by Tg B cells follow-the impaired ability to obtain switched Ab isotypes in
ing in vitro treatment with LPS or anti-CD40 plus IL-4Tg mice. Furthermore, the data suggest an aberrant
was found to be comparable to that of non-Tg B cellscontrol of IgM production in Tg mice, possibly resulting
(Figures 4D and 4E). Levels of apoptosis in Tg versusin autoimmune dysfunction.
non-Tg B cell cultures were similar as assessed by FACSIndeed, when the sera of Tg mice were assessed for
analysis with annexin V and propidium iodide labelingthe presence of auto-Ab, animals with significant dis-
(data not shown). Therefore, given their capacity to Igease (2.5- to 5.5-month-old) were found to have an in-
isotype switch following in vitro stimulation, it seemscrease in anti-DNA IgM titers (Figure 4B). Consistently,
that some anomalies of Tg B cells are not intrinsic butonly low anti-DNA Ab levels of the IgG isotypes could
rather involve a disturbed in vivo environment.be detected, in contrast to that found in the serum of
control NZB mice. Despite the increased levels of auto-
Ab in Tg animals, FACS analysis revealed no more CD5 The Development of the AIDS-like Disease in Tg
B cells in the spleen, LN, and peritoneum of Tg than Mice Does Not Require IFN-
non-Tg mice (data not shown). Since human AIDS is associated with high levels of
IFN-, including increased production by CD4 T cells
(Graziosi et al., 1996; Emilie et al., 1994; Than et al.,Peripheral B Cell Expansion in Tg Mice Is Not
1997), and given that a higher proportion of CD4 T cells
Associated with Increased Bone Marrow from Tg versus non-Tg mice produce IFN- following in
(BM) Precursors vitro stimulation, the role of this cytokine in the develop-
An increase of 25%–50% in absolute B cell numbers ment of the AIDS-like disease was investigated. CD4C/
was observed in the spleen and LN of CD4C/HIVMutA Tg HIVMutA Tg mice bred to an IFN- gene-deficient back-
mice (Hanna et al., 1998b; Figures 5 and 6). Additional ground (IFN-/) still developed an AIDS-like disease
studies have shown that the numbers of both low-den- with a slightly faster progression to death (Figure 5A).
sity and high-density small resting B cells are elevated Gross and histopathological observations were indistin-
(data not shown). We have therefore assessed the status guishable from that of wild-type (Hanna et al., 1998b)
of B cell precursors in the BM of Tg mice. The number or of heterozygote (IFN-/) Tg mice (Figures 5D and
5E). These double mutant mice also progressively lostof CD43 B220 pro-B and IgM B220 immature B
cells were not increased when compared to those of their CD4 T cells, accumulated higher B cell numbers
(Figure 5C), and produced anti-DNA IgM (Figure 5B).non-Tg mice (data not shown), suggesting that the
with sense (H) or antisense (I) probes. Spleens from non-Tg (L) or Tg (M) mice were exposed with an antisense probe. (J, K, N, and O) are
bright field images of the same regions shown in dark field in (H, I, L, and M), respectively. The scale bar in (H) represents 500  and is valid
for (H–K). The scale bar in (L) represents 1000  and is valid for (L–O). Counterstain, H&E. SC, subcapsular sinus.
Immunity
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Figure 3. Strong PNA Binding in the T Zone
of Tg Lymphoid Organs
OVA-immunized (A) and nonimmunized (B–D)
non-Tg and Tg mice were studied. PNA bind-
ing (green) and IgM expression (red) levels
and distribution in cryosections of LN taken
at day 10 following primary immunization with
OVA (A). Cryosections of LN (B), spleen (C), or
thymus (D) of nonimmunized mice. Sections
were analyzed by confocal microscopy. Data
are representative of at least two experiments
(eight mice).
IL-6-Deficient Tg Mice Still Develop 1998), and its elevated levels in a high proportion of
AIDS patients (Emilie et al., 1994; Graziosi et al., 1996;the AIDS-like Disease
Given the importance of IL-6 in B cell responses, GC Lafeuillade et al., 1991), we also assessed whether dis-
ease will develop in CD4C/HIVMutA Tg mice bred on anreactions, and auto-Ab production (Richards et al.,
Immune Dysfunctions in HIV-1 Tg Mice
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Figure 4. Reduced OVA-Specific Ig Isotype Switching, the Presence of Anti-DNA Ab, and In Vitro Function of B Cells in Tg Mice
(A) OVA-specific Ab titers in the serum of non-Tg and Tg mice taken 5 days following secondary immunization were measured by ELISA.
Each point represents the serum of one mouse at the endpoint dilution of the titration curve. The bars show mean values from six different
experiments.
(B) Anti-DNA IgM and IgG Ab levels in the sera of nonimmunized non-Tg and Tg mice were measured by ELISA. The data shown were
normalized to the DNA reactivity observed with reference sera from three autoimmune NZB mice (arbitrarily established as 100%; filled square).
Each dot represents the serum of one mouse at the endpoint dilution of the titration curve.
(C–E) Resting B cells purified from non-Tg and Tg mice were cultured with either medium alone (MA), LPS, or anti-CD40 mAb, in the presence
(D and E) or absence (C) of murine IL-4. Proliferation (C) was measured by [3H]thymidine incorporation (cpm). Data are presented as fold
increase in response over that of the value obtained with non-Tg cells in medium alone. Total levels of IgM (D) and IgG1 (E) production (g/
ml) were measured in 6-day culture supernatants. The scale bars on the graphs represent the mean of seven experiments SEM (n  7).
Student’s t test, *p  0.05; **p  0.001; ***p  0.0001.
IL-6 gene-deficient background (IL-6/). IL-6/ double opment of the AIDS-like disease leading to death as the
heterozygote (IL-6/) Tg mice (Figures 6A, 6D, and 6E).mutant Tg mice were found to be similarly susceptible
both in terms of gross and histopathology to the devel- As for IL-6/ Tg mice, IL-6/ Tg mice exhibited a de-
Immunity
180
Table 1. Ig Isotypes in the Serum of CD4C/HIVMutA Tg Mice
IgG1 IgG2b IgM IgE
Age (months) nTg Tg nTg Tg nTg Tg nTg Tg
1–3 123  16a 29  8*** 25  4 9  1.4*** 30  4 48  7* 0.013  0.006 0.04  0.02
3–5 146  28 30  6** 49  9 19  5** 33  3 45  9 0.04  0.015 0.04  0.01
5–7 138  25 43  13** 34  2 10  2*** 30  2 44  11 0.02  0.003 0.06  0.02
Total 138  14 33  5*** 34  4 13  2*** 30  2 45  5* 0.02  0.006 0.04  0.009
a Concentrations in mg/100 ml
* p  0.05, ** p  0.01, *** p  0.001, Student’s t test
1–3 months, n  13; 3–5 months, n  15; 5–7 months, n  10 each, Tg and nTg
Data are presented by mean  SEM.
crease in CD4 T cells, increased B cell numbers in their In addition, the abnormal DC phenotype and function
found in CD4C/HIVMutA Tg mice (J.P., unpublished data)LN (Figure 6C), and the production of IgM anti-DNA
auto-Ab (Figure 6B). are likely to contribute to T cell loss and impaired T cell
function (Steinman et al., 1997).
The phenotypes found in CD4C/HIVMutA Tg mice areDiscussion
characteristic of human HIV infection, where the loss of
CD4 T cells is one of the most prevalent phenotypesThe peculiarity of the CD4C/HIV Tg mice resides in the
(Shearer, 1998; Pantaleo and Fauci, 1995). CD40L ex-fact that disease development is mainly attributable to
pression is also impaired even after in vitro stimulationa single HIV-1 gene product Nef, occurring without viral
of CD4 T cells obtained from HIV-infected patientsreplication and in the absence of an immune response
(Macchia et al., 1993; Wolthers et al., 1997; Vanhamagainst HIV-1 (Hanna et al., 1998b). The specific pattern
et al., 1999). Low numbers of GC and disrupted FDCof expression in target cells naturally infected by HIV-1
networks in lymphoid organs are very prevalent featuresin humans likely explains the very high resemblance of
of advanced human AIDS (Tenner-Racz et al., 1986; Ten-this mouse disease to human AIDS. Furthermore, de-
ner-Racz and Racz, 1995; Pantaleo et al., 1993; Pilerispite the fact that virtually all target cells express HIV-1
et al., 1986), and are thought to be attributable to ain this model, its features are likely to remain relevant
concomitant contribution of cytopathic effects and ex-to human AIDS because mosaic Tg founders or chimeric
haustion of the immune response. Our data suggest thatHIV Tg mice, which harbor lower numbers of HIV cells,
the formation of GC itself and the lack of FDC networks,still develop the same AIDS-like disease, but after a
which limit B cell migration and accessibility to Ag, aslonger period of latency (Hanna et al., 1998a, 1998b).
opposed to their destruction once generated, may alsoIn the present analysis, we show that lymphoid pathol-
contribute to the impairment observed in human AIDS.ogy was accompanied by more subtle defects of im-
mune structures and associated with B cell hyperactivity
and auto-Ab production, phenomena also reported in Impaired B Cell Functions and Auto-Ab Production
AIDS (Edelman and Zolla-Pazner, 1989; Shearer, 1998; Caused by HIV-1
Root-Bernstein, 1990). Consistent with the reduced capacity to generate GC,
Ig isotype switching was decreased in response to OVA
in Tg mice. This is likely to reflect impaired delivery ofHIV-1 Impairs the Development of T Cell-Dependent
GC Reactions T cell help rather than an incapacity to switch, given
that Tg B cells respond to in vitro CD40 stimulation byOur study clearly shows that the typical T-dependent
GC formation and Ag-specific Ab maturation in response producing IgG in a similar fashion to non-Tg B cells.
Also, although GC formation was prevented in these Tgto immunization with OVA does not develop in Tg mice
and that the FDC network is greatly reduced. One of the mice, a higher proportion of large IgM cells, possibly
plasma cells, was found in both LN and spleen regard-main causes of the impaired GC formation and reduced
FDC network in these Tg mice is likely to be the lack of less of whether mice had been immunized, and was
associated with high levels of IgM and very low levelsT cell help (MacLennan, 1994; Kosco-Vilbois et al., 1997),
which is manifested in these animals by the preferential of IgG in sera. Such elevated serum IgM levels are similar
to the hyperglobulinemia reported in AIDS (Shearer,and progressive loss of peripheral CD4 T cells (Hanna
et al., 1998b) and by an impaired capacity of the re- 1998; Edelman and Zolla-Pazner, 1989). In human AIDS,
the accumulation of IgM in sera is present but not preva-maining CD4 T cells to express CD40L. CD40L plays a
pivotal role in the establishment of GC reactions, isotype lent (Moodley et al., 1997; El-Sadr et al., 1984), most
likely because GC formation and isotype switching canswitching, and generation of memory. Our observations
are consistent with those obtained with CD40/ (Ka- still occur, in contrast to that found in Tg mice. The
consequences of impaired GC reactions in human AIDSwabe et al., 1994) and CD40L/ mice (Xu et al., 1994).
Although the downregulation of CD4 may contribute to are reflected by the reduced capacity to generate effi-
cient neutralizing Ab and to produce and maintain ma-the impaired T helper functions in these Tg mice, we
present evidence with the Tg mice expressing a NefMyr ture high-affinity memory responses as the disease
progresses (Pantaleo and Fauci, 1995; Shearer, 1998;mutant allele that the phenotypes observed in these
mice are not solely the result of CD4 downregulation. Koopman and Pals, 1992).
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Figure 5. Tg Mice Deficient for IFN- Develop the AIDS-like Disease
(A) The incidence of mortality of CD4C/HIVMutA Tg mice bred on homozygote IFN-/ background (n  10) is shown in comparison with that
of Tg mice bred on a heterozygous IFN-/ background (n  7).
(B) The presence of anti-DNA IgM and IgG Ab in the sera of nonimmunized non-Tg and Tg IFN-/ mice was measured by ELISA, as described
in the legend to Figure 4. Data are representative of at least three experiments.
(C) FACS analysis shows expression of B220, CD8, and CD4 in the LN of nonimmunized non-Tg and Tg IFN-/ and IFN-/ mice.
(D and E) Kidney histology of IFN-/ non-Tg (D) and Tg (E) mice is shown. The scale bar in (E) represents 100 .
The impairment of efficient control mechanisms in the number and probably the state of activation of Tg B
cells, which were found to proliferate spontaneously ingeneration of Ab responses in Tg mice could lead to
autoimmunity. Indeed, another important characteristic vitro and to a greater extent than non-Tg B cells follow-
ing stimulation. Given that Tg B cells do not expressof the AIDS-like disease in Tg mice is the production of
auto-Ab, which are predominantly of the IgM isotype, HIV-1, further experiments will be required to determine
whether this B cell hyperreactivity is the result of aber-consistent with the impaired capacity to switch found
in these mice. Therefore, as in human AIDS, where auto- rant signals delivered by the in vivo environment and/
or whether a subpopulation of B cells is selectively acti-Ab are also frequently detected (Pantaleo and Fauci,
1995; Shearer, 1998; Root-Bernstein, 1990; Ditzel et al., vated and/or expanded in these mice.
Interestingly, B cell activation is also characteristic of1994), the present Tg model exhibits immunodeficiency
and elements of autoimmunity, both phenotypes arising human AIDS, in the early phase of the disease (Pantaleo
and Fauci, 1995; Shearer, 1998; Koopman and Pals,in the absence of IL-6, whose levels are known to be
high in human AIDS (Emilie et al., 1994; Lafeuillade et 1992; Edelman and Zolla-Pazner, 1989). Expansion of B
cell immunoblasts and increased IgM production haveal., 1991; Graziosi et al., 1996).
The accumulation of auto-Ab and the high IgM levels also been seen to occur in another HIV Tg model, al-
though in direct contrast to our observations, these Tgin the sera of Tg mice are likely to reflect the higher
Immunity
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Figure 6. Tg Mice Deficient for IL-6 Develop the AIDS-like Disease
(A) The incidence of mortality of CD4C/HIVMutA Tg mice bred on a homozygous IL-6/ background (n  10) is shown in comparison with that
of Tg mice bred on a heterozygous IL-6/ background (n  10).
(B) The presence of anti-DNA IgM and IgG Ab in the sera of nonimmunized non-Tg and Tg IL-6/ was measured by ELISA, as described in
the legend to Figure 4. Data are representative of at least three experiments. Student’s t test, *p  0.05.
(C) FACS analysis shows expression of B220, CD8, and CD4 in the LN of non-immunized non-Tg and Tg IL-6/ and IL-6/ mice.
(D and E) Kidney histology of IL-6/ non-Tg (D) and Tg (E) mice is shown. The scale bar in (E) represents 100 .
mice were thought to have expanded GC in their spleen low-grade MALT lymphomas only occasionally develop
in AIDS (Teruya-Feldstein et al., 1995). The fact that fully(Tinkle et al., 1997a). However, in these Tg mice, the
interpretation of the lymphoid organ phenotype might malignant B cell lymphomas do not arise in our Tg mice
could be due to an unfavorable genetic background.be confounded by the simultaneous presence of severe
and widespread vasculopathy leading, among other Alternatively, the absence of B cell lymphoma may re-
flect the biology of the system, especially the absencechanges, to splenic infarcts and extensive cell death
(Tinkle et al., 1997b). of GC-derived B cells in Tg mice, which may constitute
the target cells for transformation. In fact, most AIDS-Since B cells are activated and accumulate in CD4C/
HIVMutA Tg mice in the context of immunodeficiency, it associated B cell lymphomas are thought to originate
from memory B cells and are mostly the result of immunewould be expected that B cell lymphomas would arise
at a high frequency. This is intriguingly not the case, dysregulation (Koopman and Pals, 1992; Herndier et al.,
1994).although B cell lymphomas are frequently associated
with human AIDS (Koopman and Pals, 1992; Herndier
et al., 1994), and are known to be frequently accompa- Unusual Lymphoid Structure and Expansion
of the Splenic MZ in CD4C/HIV-1MutA Tg Micenied by auto-Ab production (Herndier et al., 1994). The
expansion of the MZ that we observe in Tg mice with Our immunohistochemical analysis revealed that the Tg
T cell zone was remarkable by its abnormally strong PNAits associated B cells may be the first step in the devel-
opment of such lymphomas, although MZ B cell-derived binding, both in OVA-immunized and nonimmunized Tg
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mice, apparent mostly on cells with lymphoid morphol- a T cell subpopulation, and in fact, the existence of
CD4 T cell subpopulations with regulatory propertiesogy and in larger cells with macrophage/dendritic mor-
phology. PNA has a strong affinity for GC B cells (Kosco- has already been demonstrated (Saoudi et al., 1996).
The finding that CD4C/HIVMutA Tg mice bred onto an IFN-Vilbois et al., 1997), as well as for normal thymocytes (Wu
et al., 1997) and activated peripheral effector/memory / background have a slightly faster progression to
death than their heterozygote littermates may supportCD4 and CD8 T cells (Galvan et al., 1998). Interest-
ingly, HIV-1-infected human CD4 T cells and macro- a regulatory role for IFN- in disease progression. How-
ever, IFN- itself is clearly not essential for the develop-phages have also been shown to bind strongly to PNA
(Lefebvre et al., 1994; Perrin et al., 1997). However, the ment of an AIDS-like disease or production of auto-Ab
in Tg mice.biological meaning of this strong PNA binding in Tg mice
remains unclear.
Strikingly, we found an enlargement of the splenic Conclusions
MZ in OVA-immunized Tg mice. The normal MZ is
a specialized structure containing mainly immature The numerous phenotypes observed in the CD4C/HIVMutA
Tg mice are very similar to those found in human AIDS,IgMhiIgD B cells as well as memory B cells, macro-
phages, and DC that are thought to have an important suggesting that they may share similar underlying cellu-
lar and molecular causes. We have shown that HIV-1 canrole in the generation of T cell-independent Ab responses
(Witmer and Steinman, 1984; Cyster, 2000). In the Tg modulate expression of surface molecules and affect
cellular functions, contributing to the generation of anmice, the enlarged MZ contains numerous IgMhi B cells
and numerous macrophages and DC (J.P., unpublished impaired environment which can lead to dysregulated
interactions and breakage of peripheral tolerance,data) which contribute to the large nonlymphoid PNA
binding cells in Tg MZ. Expansion of the splenic MZ is a allowing for the establishment of immunodeficiency and
the potential for autoimmune disease.rare phenotype and has been recently reported in BLC-
deficient mice (Ansel et al., 2000) and to be associated
Experimental Procedureswith the overexpression of BlyS, which also leads to B
cell hyperactivity, decreased numbers of T cells, and
Mice and Immunization
the development of an SLE-like autoimmune disease The CD4C/HIVMutA Tg mice have been previously described (Hanna
(Moore et al., 1999; Mackay et al., 1999; Cyster, 2000; et al., 1998b). The CD4C/HIV-NefMyr DNA has been constructed by
site-directed mutagenesis (G→A, position 2) of the myristilation site.Khare et al., 2000), a phenotype resembling that of
The mutated nef sequences were reintroduced in the CD4C/HIVMutGCD4C/HIVMutA Tg mice. Therefore, expansion of the MZ
DNA backbone (Hanna et al., 1998b) replacing the wild-type nef ofand generation of anti-DNA IgM in these Tg mice may
HIV-1. Tg mice were generated and founder lines expressing equalbe induced by factors secreted by HIV-1-expressing MZ
and higher levels of Nef than the CD4C/HIVMutG Tg mice were estab-
macrophages or DC, such as BlyS, which is expressed lished (Z.H., unpublished data).
by monocytes, macrophages, and DC (Cyster, 2000). Sex-matched non-Tg and Tg littermates were used between 6
and 20 weeks of age. The IFN-/ (Dalton et al., 1993), and IL-6/Interestingly, the fact that most macrophages and DC
(Kopf et al., 1994) mice were obtained from the Jackson Labora-express the HIV-1 transgene in these mice may have
tories. Animals were kept under SPF conditions. Mice (8–10 weekshelped to unravel this expanded MZ structure, which
of age) were immunized with alum-precipitated OVA (Sigma) asmay not be easily recognizable when few cells express
described previously (Poudrier et al., 1999).
HIV-1 gene products, as in HIV-1-infected individuals.
Finally, our immunohistochemical studies revealed Ab and Reagents
Ab specific for B220 (RA36B2), CD4 (GK1.5), CD8 (53.6.78), Thy 1.2the presence of large PNAhi binding cells in the surround-
(30H12), CD3	 (145-2C11), and MHC class II (M5-114) were from theings of large IgM cells which are probably plasma cells,
ATCC. The anti-FDC-M2 (209) mAb has been described (Kosco-both cell types being increased in the red pulp of Tg
Vilbois et al., 1997). Anti-CD69, -CD44, -CD45Rb, -Mac-1, -IAk, -B7-1,mice. This cell association could reflect an ongoing acti-
and -B7-2 were from Cederlane. The Pan-NK cell DX5, anti-CD5.1,
vation process leading to plasma cell differentiation and and anti-CD40L mAb were from Pharmingen. Goat anti-mouse IgM-
survival. Texas-red, Cy5-streptavidin, and FITC-streptavidin were from South-
ern Biotechnology Associates. Mouse anti-rat IgG F(ab
)2-FITC was
obtained from Jackson Immunoresearch Laboratories. BiotinylatedDevelopment of the AIDS-like Disease in CD4C/HIVMutA
PNA was from Vector. Anti-CD40 (FGK-45) was from Dr. A. RolinkTg Mice Does Not Require IFN-
(Basel Institute for Immunology, Switzerland). Anti-CD28 (37.51) was
It has been proposed, but not confirmed, that human from Dr. P. Hugo (Procrea, Canada). Mouse recombinant IL-4 was
AIDS development is associated with a Th1 to Th2 cyto- from the X63-mIL-4-transfected plasmacytoma (Karasuyama and
Melchers, 1988).kine shift (Clerici and Shearer, 1994; Graziosi et al.,
1994), although a role for these cytokines in progression
Isolation of T and B Cellsto AIDS has yet to be elucidated. We found that a higher
High-density cells from LN or spleen of nonimmunized Tg or non-percentage of Tg than non-Tg CD4T cells were capable
Tg mice were isolated on Percoll (Pharmacia) gradients. Further
of producing IFN- following in vitro activation, a finding purification involved the depletion of contaminating cells using mag-
consistent with the high levels of IFN- reported in hu- netic beads (Dynal) following preincubation with hybridoma super-
natants. This resulted in 95% CD4 T cells or B220 B cells.man AIDS, including in CD4 T cells (Graziosi et al.,
1994, 1996; Emilie et al., 1994; Than et al., 1997). The
In Vitro CD4 T Cell and B Cell Activationincreased IFN--producing Tg CD4T cells might reflect
Cells were cultured in Iscove’s modified Dulbecco medium supple-a direct effect of HIV-1 and may be an adaptive response
mented with 5% FBS, L-glutamine (Gibco BRL), 2-ME, and antibiot-
to favor virus production, since IFN- has been shown ics. For stimulation, CD4 T cells were cultured on anti-CD3 (10 g/
to activate HIV-1 expression (Koyanagi et al., 1988). ml)-coated plates in the presence of anti-CD28 (25% supernatant).
B cells were cultured with either LPS (Sigma; 10 g/ml) or anti-Also, HIV-1 may favor an outgrowth and/or selection of
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CD40 (25% supernatant), in the presence or absence of IL-4 (25% T lymphocytes and macrophages by HIV during the incubation pe-
riod of AIDS. Nature 362, 359–362.supernatant). Proliferation was measured by [3H]thymidine (1 Ci/
well; Amersham) incorporation for the final 18 hr of a 48-hr culture Emilie, D., Fior, R., Crevon, M.C., Maillot, M.C., Boue, F., and Gala-
period. naud, P. (1994). Cytokines from lymphoid organs of HIV-infected
Ig were detected by standard ELISA procedures using plates patients: production and role in the immune disequilibrium of the
coated with either OVA (1 g/ml), goat anti-mouse IgM or IgG (1 disease. Res. Immunol. 145, 595–600.
g/ml; Southern Biotechnology Associates), or sonicated double-
Emilie, D., Zou, W., Fior, R., Llorente, L., Durandy, A., Crevon, M.C.,
stranded human placenta DNA (200–300 bp; 4 g/ml). HRP-coupled
Maillot, M.C., Durand-Gasselin, I., Raphael, M., Peuchmaur, M., and
goat anti-mouse IgM, IgG1, IgG2a, IgG2b, and IgE Ab (Southern
Galamaud, P. (1997). Production and roles of IL-6, IL-10, and IL-13
Biotechnology Associates) were used to reveal isotypes. OPD
in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of
(Sigma) was used as a substrate.
HIV infection and autoimmunity. Methods 11, 133–142.
Fox, C.H., Tenner-Racz, K., Racz, P., Firpo, A., Pizzo, P.A., and Fauci,Immunofluorescence
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